Jayakumar R Nair
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 24, 2026
DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers.Tzu-Ting Huang, Jayakumar R Nair, Courtney Bowen
|Dec 08, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.Takeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz
|Jan 19, 2024
AKT1 interacts with DHX9 to Mitigate R Loop-Induced Replication Stress in Ovarian Cancer.Tzu-Ting Huang, Chih-Yuan Chiang, Jayakumar R Nair
|Jun 21, 2023
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer.Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair
|Oct 01, 2020
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer.Tzu-Ting Huang, Ethan Brill, Jayakumar R Nair
|Jul 11, 2020
Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer.Jayakumar Nair, Tzu-Ting Huang, Junko Murai
Pageof 1
Frequent Collaborators
4 joint publications
Jung-Min Lee
4 joint publications
Tzu-Ting Huang
2 joint publications
Darryl Nousome
2 joint publications
Kelli M Wilson
1 joint publications
Serena J Silver
1 joint publications
Ashley Cimino-Mathews
1 joint publications
Stanley Lipkowitz
1 joint publications
Min-Jung Lee
1 joint publications
Alexandra Zimmer
1 joint publications
Shraddha Rastogi
